INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

359 studies · page 8 of 15

2014 / Narrative review

Obesity is linked to hepatocellular carcinoma via mechanisms including chronic inflammation, lipotoxicity, altered gut microbiota, and insulin resistance.

This review details how obesity and related metabolic conditions contribute to hepatocarcinogenesis. Obesity-associated hepatocellular carcinoma is attributed to chronic inflammation from adipose remodeling, pro-inflammatory adipokine secretion, ectopic lipid accumulation, altered gut microbiota, disrupted stellate cell senescence, and insulin resistance with elevated insulin and insulin-like growth factors. These pathways synergize with chronic liver disease from other etiologies to accelerate hepatocellular carcinoma development.

Shows an association, not proof of cause and effect.

Karagozian R, Derdák Z, Baffy G Metabolism, 2014. PMID 24629562

2014 / Narrative review

A review notes that sugar-sweetened beverage consumption plays a role in the epidemic of obesity, metabolic syndrome, and fatty liver disease.

This narrative review examined data on dietary sugar consumption and related health risks, including NHANES, USDA surveys, meta-analyses, and randomized controlled trials. About 75% of foods and beverages contain added sugar, and soft drink consumption has increased fivefold since 1950. Meta-analyses indicate sugar-sweetened beverage (SSB) intake is related to risks of diabetes, metabolic syndrome, and cardiovascular disease, and drinking two 16-ounce SSBs daily for 6 months induced metabolic syndrome features and fatty liver. Trials lasting 6 months to 2 years showed that lowering soft drink intake reduced weight gain.

Bray GA, Popkin BM Diabetes Care, 2014. PMID 24652725

2014 / Narrative review / counterpoint

Authors argue there is no clear evidence that dietary sugar uniquely impacts the development of obesity or diabetes compared to other calorie sources.

In this counterpoint narrative, the authors respond to arguments proposing reduced dietary sugar consumption to address obesity and type 2 diabetes. They argue that there is no clear or convincing evidence that any dietary or added sugar has a unique or detrimental impact compared to other caloric sources on developing obesity or diabetes. They note sugar is purely a palatable energy source that is not essential, and while cutting sugar can reduce energy intake, doing so does not automatically portend clinical benefit.

Kahn R, Sievenpiper JL Diabetes Care, 2014. PMID 24652726

2014 / Narrative review

A review evaluates evidence linking bisphenol A (BPA) exposure from food packaging to obesity and type 2 diabetes.

This review examines literature investigating the association between bisphenol A (BPA) and alterations in metabolic health. It discusses daily BPA exposure levels, evaluates human epidemiologic data and mechanistic preclinical studies regarding obesity and diabetes, and summarizes current views from regulatory agencies.

Shows an association, not proof of cause and effect.

Mirmira P, Evans-Molina C Transl Res, 2014. PMID 24686036

2014 / Narrative review

A review evaluates human studies investigating the effects of seaweed and its bioactive components on markers of health and chronic disease.

Seaweeds are rich in unique bioactive compounds such as specific proteins, polyphenols, and polysaccharides with purported antiviral, anticancer, anticoagulant, gut health, obesity, and diabetes benefits. Although most research has been conducted in cell and animal models, evidence exists for the beneficial effects of seaweed and seaweed components on markers of human health and disease status. This review critically evaluates these human studies to highlight gaps in current knowledge and support future research planning.

Brown ES, Allsopp PJ, Magee PJ, et al. Nutr Rev, 2014. PMID 24697280

2014 / Review

Iron overload contributes to organ damage in chronic metabolic diseases, while iron depletion can exert beneficial effects.

This review discusses the impact of iron overload on chronic metabolic diseases such as type 2 diabetes, obesity, non-alcoholic fatty liver disease, and atherosclerosis. Iron overload affects glucose and lipid metabolism in tissues like pancreatic β cells, liver, muscle, and adipose tissue, resulting in organ damage. Conversely, iron depletion can exert beneficial effects in patients with iron overload and in healthy frequent blood donors. The authors suggest regular assessment of iron balance for patients with chronic metabolic diseases.

Fernández-Real JM, Manco M Lancet Diabetes Endocrinol, 2014. PMID 24731656

2014 / Narrative review of human and animal studies

Time-restricted feeding is linked to reductions in body weight and improvements in lipid and glucoregulatory markers in animals and humans.

This review summarized the literature on the effects of time-restricted feeding (TRF) on body weight and metabolic disease risk markers in animals and humans. Animal studies showed TRF was associated with reduced body weight, total cholesterol, triglycerides, glucose, insulin, IL-6, and TNF-alpha, alongside improved insulin sensitivity. Human data supported these findings, demonstrating decreased body weight (though not consistently), lower triglycerides, glucose, and LDL cholesterol, and higher HDL cholesterol.

Rothschild J, Hoddy KK, Jambazian P, et al. Nutr Rev, 2014. PMID 24739093

2014 / Narrative review

Dietary factors and gut microbiota dysbiosis appear to influence type 1 diabetes development, though evidence remains inconclusive.

This review examines the influence of dietary and environmental factors, alongside gut microbiota, on type 1 diabetes (T1D) etiology in humans and animal models. Even in mono-zygotic twins, the concordance rate is only around 50%, highlighting the role of non-genetic factors. Although data remain inconclusive, there are strong indications that gut microbiota dysbiosis plays an important role, and animal models suggest manipulating the gut microbiota may be valuable for future prevention in genetically susceptible individuals.

Nielsen DS, Krych Ł, Buschard K, et al. FEBS Lett, 2014. PMID 24746688

2014 / Narrative review

Gut microbiota dysbiosis, including reduced levels of butyrate-producing bacteria, is linked to type 2 diabetes and metabolic alterations.

This review discusses the relationship between gut microbiota, obesity, and type 2 diabetes (T2D). Human metagenome-wide association studies show significant correlations between specific intestinal bacteria, bacterial genes, and metabolic pathways with T2D. Notably, concentrations of butyrate-producing bacteria such as Roseburia intestinalis and Faecalibacterium prausnitzii were lower in T2D subjects. Additionally, gut-derived endotoxaemia is observed in metabolic syndrome and T2D, and specific bacteria like Akkermansia muciniphila may be decreased in diabetes and exert antidiabetic effects in murine models.

Shows an association, not proof of cause and effect.

Tilg H, Moschen AR Gut, 2014. PMID 24833634

2014 / Narrative review of prospective cohort studies

In Adventist cohorts, vegetarian and vegan diets were associated with lower risks of cardiovascular disease, diabetes, hypertension, and mortality.

This review evaluated evidence from three prospective cohorts of North American Adventists (Adventist Mortality Study, Adventist Health Study, and Adventist Health Study-2) comparing non-vegetarian to vegetarian patterns. Vegetarian diets conferred protection against cardiovascular diseases, cardiometabolic risk factors, some cancers, and total mortality. Compared with lacto-ovo-vegetarian diets, vegan diets appeared to offer additional protection against obesity, hypertension, type-2 diabetes, and cardiovascular mortality, with males experiencing greater health benefits than females. The authors note limited prospective data on vegetarian diets and body weight change.

Shows an association, not proof of cause and effect.

Le LT, Sabaté J Nutrients, 2014. PMID 24871675

2014 / Narrative review

Plant-based dietary patterns and components like fiber may alter the gut microbiota to influence cardiometabolic risk.

This review examines the influence of dietary patterns and their components on the gut microbiota and cardiometabolic outcomes. Dietary patterns emphasizing plant-based foods, such as vegetarian and vegan diets, have been linked to a reduced risk of cardiovascular events and diabetes incidence. These diets provide high levels of dietary fiber and fermentable substrates that gut microbes ferment into short-chain fatty acids, which may modulate host health. Prebiotics and resistant starches are noted as dietary components that alter gut microbial composition.

Wong JM Am J Clin Nutr, 2014. PMID 24898225

2014 / Narrative review

A review notes limited evidence for the thrifty gene hypothesis and highlights alternative evolutionary hypotheses for the obesity epidemic.

Obesity, diabetes, and metabolic syndrome represent escalating worldwide health challenges with incompletely understood causes. This review examines evidence surrounding the thrifty gene hypothesis, which posits obesity as an evolutionary adaptation for famine survival, noting that supporting evidence is limited. It presents alternative hypotheses regarding the evolutionary origins of obesity, emphasizing that these alternatives suggest distinctly different research and clinical management strategies.

Genné-Bacon EA Yale J Biol Med, 2014. PMID 24910556

2014 / Conference proceedings

A summit identified the need to clarify fiber sources and promote diverse foods to help Americans meet daily fiber recommendations.

The Food & Fiber Summit convened nutrition researchers, educators, and communicators to address persistently low fiber intake in America, which remains at approximately half of recommended amounts. Adequate fiber intake is associated with reduced risk for cardiovascular disease, cancer, diabetes, certain gastrointestinal disorders, and obesity. Summit outcomes emphasized addressing consumer confusion regarding fiber sources, recognizing benefits of various fiber types, and identifying practical opportunities across meal occasions and food categories to increase intake.

Shows an association, not proof of cause and effect.

Mobley AR, Jones JM, Rodriguez J, et al. Nutrients, 2014. PMID 25006857

2014 / Narrative review

A review indicates DHEA supplementation may offer immunomodulatory, musculoskeletal, and metabolic benefits in certain human populations.

This review evaluates evidence regarding dehydroepiandrosterone (DHEA) supplementation. Double-blind, placebo-controlled human trials in the elderly show DHEA increases monocytes, TCRγδ T cells, and NK cells, while improving well-being, muscle strength, bone density, and reducing body fat and skin atrophy. In adrenal insufficiency, it restores hormone levels, lowers total cholesterol, improves insulin sensitivity, and preserves bone mineral density. In women, DHEA improves sexual satisfaction, fertility, and vaginal atrophy, though studies remain inconsistent due to dosing differences, rapid metabolism, and other factors.

Rutkowski K, Sowa P, Rutkowska-Talipska J, et al. Drugs, 2014. PMID 25022952

2014 / Phytochemical and pharmacological review

Hibiscus sabdariffa extracts show antioxidant, anti-hypertensive, and metabolic effects, but well-designed trials with characterized preparations are needed.

This review evaluates the phytochemical and pharmacological evidence for Hibiscus sabdariffa L. (Hs, roselle). In vitro and in vivo studies, along with some clinical trials, show antibacterial, antioxidant, nephro- and hepato-protective, diuretic, lipid-lowering, anti-diabetic, and anti-hypertensive effects. Proposed mechanisms include antioxidant actions, enzyme inhibition (α-glucosidase, α-amylase, ACE), and vaso-relaxant effects, likely driven by phenolic acids, organic acids, and anthocyanins. The authors note an excellent safety and tolerability record, but emphasize that most evidence is based on poorly characterized extracts and more well-designed controlled clinical trials using characterized preparations are needed.

Da-Costa-Rocha I, Bonnlaender B, Sievers H, et al. Food Chem, 2014. PMID 25038696

2014 / Literature review

A review of eight observational studies found plant-based diets were generally linked to a lower risk of metabolic syndrome compared with omnivorous diets.

This review examined eight observational studies (and no intervention studies) evaluating vegetarian and vegan diets in relation to metabolic syndrome, conducted mostly in Asian populations. The studies yielded varying results, but the majority reported better metabolic risk factors and lower metabolic syndrome risk among those following plant-based diets compared with omnivores. The authors noted plant-based diets are lower in energy, saturated fat, heme iron, and red and processed meat, and higher in fruits, vegetables, and fiber.

Shows an association, not proof of cause and effect.

Turner-McGrievy G, Harris M Curr Diab Rep, 2014. PMID 25084991

2014 / Narrative review

Walnut consumption is linked to lower risks of cancer, cardiovascular disease, diabetes, and mortality in published literature.

This review discusses the translation of clinical and epidemiological research on diet, inflammation, and cancer risk using walnuts as a case example. Published literature documents associations between walnut intake and reduced risks of cancer, diabetes, cardiovascular disease, and mortality, particularly within Mediterranean diet patterns. The authors note that follow-up in human intervention trials is needed to better understand any direct cancer-preventive effects of walnuts.

Shows an association, not proof of cause and effect.

Toner CD Nutr Res Pract, 2014. PMID 25110552

2014 / Narrative review

Vinegar may reduce hyperglycemia, hyperinsulinemia, hyperlipidemia, and obesity, though findings across studies remain mixed.

This review summarizes the effects of vinegar on glucose and lipid metabolism. Several studies showed that vinegar can help reduce hyperglycemia, hyperinsulinemia, hyperlipidemia, and obesity, while other studies reported no beneficial metabolic effects. Proposed mechanisms include delayed gastric emptying, suppressed hepatic glucose production, increased glucose utilization, reduced lipogenesis, and increased satiety. The authors note that further large-scale, long-term trials are warranted before definitive health claims can be made.

Petsiou EI, Mitrou PI, Raptis SA, et al. Nutr Rev, 2014. PMID 25168916

2014 / Bibliometric analysis of randomized controlled trials

A bibliometric analysis of 312 RCTs evaluated the characteristics of yoga trials conducted between 1975 and 2014 across 22,548 participants.

This bibliometric analysis evaluated the characteristics of yoga RCTs published between 1975 and February 2014. A total of 366 papers reporting 312 RCTs with 22,548 participants were included, with a median sample size of 59. Adults were studied in 84.6% of RCTs, older adults in 33.7%, and healthy participants in 26.9%; common medical conditions included breast cancer (5.4%), depression (4.5%), asthma (4.5%), and type 2 diabetes mellitus (4.2%). Interventions had a median duration of 9 weeks, with 78.2% using postures and 74.4% using breath control, while 55.6% compared yoga to no specific treatment.

Cramer H, Lauche R, Dobos G BMC Complement Altern Med, 2014. PMID 25183419

2014 / Narrative review

Flaxseed, flaxseed oil, and its components provide potential health benefits against cardiovascular disease, diabetes, cancer, and other disorders.

This review summarizes evidence from recent human and animal studies on the health benefits and commercial applications of flaxseed. Flaxseed is rich in α-linolenic acid, lignans, fiber, and protein. These components are linked to potential benefits in reducing cardiovascular disease, atherosclerosis, diabetes, cancer, arthritis, osteoporosis, and autoimmune and neurological disorders.

Goyal A, Sharma V, Upadhyay N, et al. J Food Sci Technol, 2014. PMID 25190822

2014 / Systematic review

Dietary intake of advanced glycation end products appears related to inflammatory status and circulating AGEs.

A systematic review of 17 human or animal studies evaluated the relationship between dietary advanced glycation end products (AGEs) and inflammatory processes. Human intervention studies mainly showed a decrease in inflammation on a low-AGE diet, while an increase on a high-AGE diet was less apparent; about half of observational studies found a link. Overall, limiting dietary AGE intake may decrease inflammation and related chronic conditions, though most trials were in patients with diabetes or chronic kidney disease.

Van Puyvelde K, Mets T, Njemini R, et al. Nutr Rev, 2014. PMID 25231200

2014 / Narrative review

Diabetes and chronic hyperglycemia are linked to increased incidence, progression, and mortality in several cancers.

This review discusses the link between diabetes mellitus, particularly type 2 diabetes, and cancer. Cancers including pancreatic, liver, breast, and female reproductive cancers display higher prevalence and mortality in diabetic patients compared to healthy subjects. Potential drivers of increased tumor growth include hyperinsulinemia, chronic inflammation, and hyperglycemia, though exact molecular mechanisms remain incompletely understood.

Shows an association, not proof of cause and effect.

Ryu TY, Park J, Scherer PE Diabetes Metab J, 2014. PMID 25349819

2014 / Narrative review / global modeling analysis

Global shifts toward refined foods and meats are linked to increased chronic diseases and agricultural greenhouse gas emissions.

Rising incomes and urbanization drive dietary transitions replacing traditional diets with foods higher in refined sugars, refined fats, oils, and meats. By 2050, these unchecked trends are estimated to contribute to an 80 percent increase in global agricultural greenhouse gas emissions and greater land clearing. Furthermore, these dietary shifts increase the incidence of type II diabetes, coronary heart disease, and other chronic non-communicable diseases. Alternative diets offering health benefits could reduce greenhouse emissions, limit land clearing, and help prevent diet-related chronic diseases.

Shows an association, not proof of cause and effect.

Tilman D, Clark M Nature, 2014. PMID 25383533

2014 / Review of pooled/meta-analyses and systematic reviews

A review of 304 meta-analyses and systematic reviews found plant foods, especially grains, and tea were linked to lower diet-related chronic disease risk.

This review synthesized 304 pooled/meta-analyses and systematic reviews published between 1950 and 2013 examining associations between 17 food/beverage groups and 10 diet-related chronic diseases (DRCDs). Plant food groups were found to be more protective than animal food groups, with grain products being more protective than fruits and vegetables. Dairy/milk products showed a neutral effect, while red/processed meats tended to increase risk; tea was the most protective beverage and soft drinks the least. Overweight/obesity, type 2 diabetes, cardiovascular diseases, and cancers accounted for 289 of the reviews, while no reviews were identified for sarcopenia or kidney disease.

Shows an association, not proof of cause and effect.

Fardet A, Boirie Y Nutr Rev, 2014. PMID 25406801